YaoGeJu

Company directoryChina company filings

Medisan Pharmaceutical Co., Ltd.Lanxi

As of 18 November 2026, for the company name Medisan Pharmaceutical Co., Ltd.Lanxi as recorded, the chemical-drug catalogue lists 2 active records with this name as holder; 47 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

12 acceptance records as first applicant, grouped into 10 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Dotinurad Tablets 2 records · Latest accepted 2026/10/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602480Generic2026/10/10Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
CYHS2602479Generic2026/10/10Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Ertugliflozin Tablets 1 records · Latest accepted 2026/09/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602432Generic2026/09/29Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Olopatadine Hydrochloride Granules 1 records · Latest accepted 2025/10/24

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503792Generic2025/10/24Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Pemafibrate Tablets 1 records · Latest accepted 2025/07/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502743Generic2025/07/30Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
生理氯化钠溶液 · No verified English name 1 records · Latest accepted 2025/07/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501480Supplement2025/07/24Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.CDE ↗
Amlodipine Besylate and Benazepril Hydrochloride Capsules 1 records · Latest accepted 2025/03/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501035Generic2025/03/13Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Omeprazole Sodium for Injection 1 records · Latest accepted 2025/01/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402259Supplement2025/01/01Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.CDE ↗
甘露醇注射液 · No verified English name 2 records · Latest accepted 2024/07/16

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401049Supplement2024/07/16Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.CDE ↗
CYHB2401048Supplement2024/07/16Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.CDE ↗
Risperidone Orally Disintegrating Tablets 1 records · Latest accepted 2023/07/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301879Generic2023/07/13Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Tandospirone Citrate Tablets 1 records · Latest accepted 2022/04/24

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200635Generic2022/04/24Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗

Changes in the last 90 days

4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 3 applicationsNo longer listed under review: 1 application

  1. 2026/11/11No longer listed under review

    Ertugliflozin Tablets

    CYHS2602432

    Fact date: 2026/11/11 · Date added to this site: 2026/11/11

    Accepted: 2026/09/29

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/10/10Accepted

    Dotinurad Tablets

    CYHS2602480

    Fact date: 2026/10/10 · Date added to this site: 2026/10/22

    View source ↗
  3. 2026/10/10Accepted

    Dotinurad Tablets

    CYHS2602479

    Fact date: 2026/10/10 · Date added to this site: 2026/10/22

    View source ↗
  4. 2026/09/29Accepted

    Ertugliflozin Tablets

    CYHS2602432

    Fact date: 2026/09/29 · Date added to this site: 2026/10/22

    View source ↗

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Dotinurad Tablets CYHS2602480Generic2026/10/10Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Dotinurad Tablets CYHS2602479Generic2026/10/10Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Olopatadine Hydrochloride Granules CYHS2503792Generic2025/10/24Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Pemafibrate Tablets CYHS2502743Generic2025/07/30Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗

Catalogue holder records

2 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Risperidone Orally Disintegrating TabletsMedisan Pharmaceutical Co., Ltd.LanxiMedisan Pharmaceutical Co., Ltd.Lanxi国药准字H202490622024/10/16Generic approved under the new chemical-drug registration classificationCDE ↗
Tandospirone Citrate TabletsMedisan Pharmaceutical Co., Ltd.LanxiMedisan Pharmaceutical Co., Ltd.Lanxi国药准字H202343822023/10/27Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

47 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
右莰醇 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20260000805I2026/10/15CDE ↗
葡萄糖酸氯己定溶液 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20260000730I2026/09/01CDE ↗
奈妥匹坦 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20260000359I2026/05/19CDE ↗
巴瑞替尼 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20250001134I2025/11/11CDE ↗
硫酸瑞美吉泮 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20250001049I2025/09/30CDE ↗
吲哚菁绿 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20250000724I2025/09/08CDE ↗
盐酸曲唑酮 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20250000868I2025/08/26CDE ↗
环磷腺苷 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20250000100A2026/07/28CDE ↗
非奈利酮 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20240001327A2026/07/14CDE ↗
磷酸芦可替尼 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20240001324A2026/08/07CDE ↗
氯诺昔康 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20240000025I2025/08/13CDE ↗
盐酸兰地洛尔 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230001330A2025/07/22CDE ↗
布瑞哌唑 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230001153A2026/03/06CDE ↗
盐酸莫西沙星 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230001071A2025/07/22CDE ↗
甲磺酸倍他司汀 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230000146A2024/12/13CDE ↗
罗沙司他 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230000408A2024/12/20CDE ↗
米铂 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230000215I2023/05/10CDE ↗
醋酸曲普瑞林 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20230000001A2024/08/22CDE ↗
盐酸倍他司汀 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20220001031A2025/10/30CDE ↗
盐酸昂丹司琼 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20220000619A2025/05/09CDE ↗
奥美拉唑钠 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20220000336A2023/12/21CDE ↗
枸橼酸坦度螺酮 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20220000248A2025/02/20CDE ↗
马来酸阿塞那平 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20220000119I2022/03/25CDE ↗
阿立哌唑 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20210000981A2024/01/17CDE ↗
奥扎格雷钠 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20210000850A2024/01/17CDE ↗
奥氮平 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20210000364A2024/01/17CDE ↗
左乙拉西坦 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20200000517I2020/05/21CDE ↗
右泛醇 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190008338A2024/06/06CDE ↗
尼麦角林 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190006814A2024/06/06CDE ↗
米氮平 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190006388A2026/04/13CDE ↗
丙氨酰谷氨酰胺 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005728A2025/09/19CDE ↗
甲钴胺 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005725A2025/09/19CDE ↗
穿琥宁 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005529A2025/08/16CDE ↗
炎琥宁 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005521A2025/08/16CDE ↗
细辛脑 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005477A2025/08/16CDE ↗
奥扎格雷 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005471A2025/04/23CDE ↗
甲磺酸加贝酯 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005456A2025/08/16CDE ↗
盐酸艾司洛尔 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005455A2025/09/18CDE ↗
葡萄糖酸依诺沙星 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005454A2024/05/24CDE ↗
新鱼腥草素钠 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005453A2024/06/06CDE ↗
卡络磺钠 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190005452A—CDE ↗
羟乙基淀粉130/0.4 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190001364A2024/06/06CDE ↗
奥沙利铂 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190001328A2024/06/06CDE ↗
异环磷酰胺 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190001301A2024/06/06CDE ↗
维库溴铵 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190001271A2024/06/06CDE ↗
奥拉西坦 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20190000037A2025/12/16CDE ↗
L-苹果酸 · No verified English nameMedisan Pharmaceutical Co., Ltd.LanxiY20170001079A2026/07/06CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

36 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Trazodone Hydrochloride Sustained-release Tablets CYHS2602804Generic2026/11/13HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Pemafibrate Tablets CYHB2601657Supplement2026/08/31Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Amlodipine Besylate and Benazepril Hydrochloride Capsules CYHB2601439Supplement2026/07/27Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
氟比洛芬凝胶贴膏 · No verified English name CYHS2601633Generic2026/07/08HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
枸橼酸钠血滤置换液 · No verified English name CYHS2600939Generic2026/04/24HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Finerenone Tablets CYHB2600609Supplement2026/03/27Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Finerenone Tablets CYHB2600608Supplement2026/03/27Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Finerenone Tablets CYHS2504169Generic2025/12/04HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Finerenone Tablets CYHS2504168Generic2025/12/04HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Agomelatine Tablets CYHS2503572Generic2025/09/29Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
生理氯化钠溶液 · No verified English name CYHS2503355Generic2025/09/10HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Finerenone Tablets CYHS2503245Generic2025/09/03Anhui Wan Bang Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Finerenone Tablets CYHS2503244Generic2025/09/03Anhui Wan Bang Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Trazodone Hydrochloride Sustained-release Tablets CYHS2502782Generic2025/08/02HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Paracetamol and Ibuprofen Tablets CYHS2501980Generic2025/06/05HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Aminophylline Tablets CYHS2500988Generic2025/03/10HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Ruxolitinib Phosphate Tablets CYHS2500362Generic2025/01/20HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Ruxolitinib Phosphate Tablets CYHS2500361Generic2025/01/20HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Ruxolitinib Phosphate Tablets CYHS2500360Generic2025/01/20HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Betahistine Mesilate Tablets CYHS2404092Generic2024/11/28HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Moxifloxacin Hydrochloride Tablets CYHS2403863Generic2024/11/12Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride Injection CYHB2401839Supplement2024/11/07HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Sodium Thiosulfate Injection CYHS2403392Generic2024/10/12Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Brexpiprazole Tablets CYHS2402764Generic2024/08/23HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Brexpiprazole Tablets CYHS2402763Generic2024/08/23HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Brexpiprazole Tablets CYHS2402259Generic2024/07/18HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Brexpiprazole Tablets CYHS2402257Generic2024/07/18HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride Injection CYHB2400799Supplement2024/06/12HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Nimodipine Tablets CYHS2401587Generic2024/05/28HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Morinidazole and Sodium Chloride Injection CYHS2303528Generic2023/12/20Sichuan Shang Shan Liu Jing Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Roxadustat Capsules CYHS2302026Generic2023/07/29HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Roxadustat Capsules CYHS2302025Generic2023/07/29HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
杏芎氯化钠注射液 · No verified English name CYHB2300624Supplement2023/03/28Hong He Pharmaceutical Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Olanzapine Tablets CYHS2200979Generic2022/06/30HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride Injection CYHS2101274Generic2021/06/08Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗
氟比洛芬凝胶贴膏 · No verified English name CYHS2100166Generic2021/02/05HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.LanxiCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.